Global Clinical Trial Market Growth (Status and Outlook) 2023-2029

Global Clinical Trial Market Growth (Status and Outlook) 2023-2029

Product Code:459179

Published Date: Feb 08,2023

Pages: 102

Region: Global

Category: Medical Care

PDF DOWNLOAD

GET FREE SAMPLE

CUSTOMIZE REQUEST

PDF DOWNLOAD

GET FREE SAMPLE

CUSTOMIZE REQUEST

SELECT A FORMAT

ADD TO BASKET

BUY NOW

Provide comprehensive and accurate analysis and reports according to your exact requirements

Provide comprehensive and accurate analysis and reports according to your exact requirements

CONTACT US

Clinical trials are experiments or observations done in clinical research. Such prospective biomedical or behavioral research studies on human participants are designed to answer specific questions about biomedical or behavioral interventions, including new treatments (such as novel vaccines, drugs, dietary choices, dietary supplements, and medical devices) and known interventions that warrant further study and comparison. Clinical trials generate data on safety and efficacy. They are conducted only after they have received health authority/ethics committee approval in the country where approval of the therapy is sought. These authorities are responsible for vetting the risk/benefit ratio of the trial – their approval does not mean that the therapy is 'safe' or effective, only that the trial may be conducted.

LPI (LP Information)' newest research report, the “Clinical Trial Industry Forecast” looks at past sales and reviews total world Clinical Trial sales in 2022, providing a comprehensive analysis by region and market sector of projected Clinical Trial sales for 2023 through 2029. With Clinical Trial sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Clinical Trial industry.

This Insight Report provides a comprehensive analysis of the global Clinical Trial landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Clinical Trial portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Clinical Trial market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Clinical Trial and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Clinical Trial.

The global Clinical Trial market size is projected to grow from US$ 45650 million in 2022 to US$ 84150 million in 2029; it is expected to grow at a CAGR of 9.1% from 2023 to 2029.

The industry's leading producers are Parexel, PRA Health and LabCorp (Covance), which accounted for 4.94%, 7.25% and 11.81% of revenue in 2019, respectively. By region, North America has the highest share of income, at more than 39 percent.

This report presents a comprehensive overview, market shares, and growth opportunities of Clinical Trial market by product type, application, key players and key regions and countries.

Market Segmentation:
Segmentation by type
    Instruments(Products)
    Consumables
    Others

Segmentation by application
    Procurement and Supplies
    Rentals
    Others

This report also splits the market by region:
    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
    Fisher Clinical Services
    Myoderm
    Bilcare
    CliniChain
    Ancillare
    MESM
    ERG Holding
    Apex Medical Research
    Parexel
    PRA Health
    LabCorp (Covance)
    Marken
    AmerisourceBergen (World Courier)